Early midodrine treatment for ascites in liver failure
Treatments studied
Part of Digestive system clinical trials.
This study tests whether starting a medicine called midodrine early can help control belly fluid buildup (ascites) and its problems in people with acute-on-chronic liver failure. The goal is to see if it helps you feel better and avoid serious complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have acute-on-chronic liver failure (ACLF) — a sudden worsening of long-term liver disease.
- You must have moderate to severe fluid buildup in your belly (ascites).
- You must be able to follow a low-salt diet, collect urine samples, and come for regular checkups.
- You may not qualify if you have active kidney injury, severe infections, bleeding problems, very low blood pressure, or if you need intensive care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether lowering ammonia levels with medications can prevent serious liver-related problems in people with acute-on-chronic liver failure who do not yet have confusion. Participation involves receiving medication to reduce ammonia, which may help avoid complications.
This trial tests a new drug called AS1501 for people with acute-on-chronic liver failure (a sudden worsening of chronic liver disease). It aims to see if the drug can help improve liver function and reduce the need for a liver transplant. You may be eligible if you are in the early or middle stage of this condition and have a specific blood marker (high TRAIL level).
This study tests a medicine called finerenone to see if it can prevent kidney disease in people who have cirrhosis (liver scarring) with fluid buildup in the belly (ascites) due to fatty liver disease. Taking part may help protect your kidneys.
This trial tests a pill called midodrine to see if it can safely raise blood pressure in people with heart failure and low blood pressure. It may help you feel better and avoid needing IV treatments while in the hospital.
This Phase 2 trial tests whether high-dose albumin can reduce “refractory ascites,” which is fluid buildup in the belly that doesn’t improve with the highest tolerated water pills (diuretics). If you have liver cirrhosis and need frequent drainage, this study may offer a new treatment option.
This trial tests if taking branched-chain amino acids by mouth can help people with cirrhosis and ascites (fluid in the belly). It aims to improve nutrition and reduce complications.
Hear when a new Acute-On-Chronic Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.